China Shineway Pharmaceutical Group Limited (HKG:2877)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.48
+0.10 (1.19%)
Jun 1, 2026, 4:08 PM HKT
Market Cap6.33B +17.7%
Revenue (ttm)3.49B -17.0%
Net Income1.06B +13.1%
EPS1.40 +13.3%
Shares Out 755.40M
PE Ratio5.99
Forward PE5.72
Dividend0.54 (6.49%)
Ex-Dividend DateMay 4, 2026
Volume948,000
Open8.23
Previous Close8.38
Day's Range8.23 - 8.53
52-Week Range7.25 - 10.47
Beta0.83
Analystsn/a
Price Targetn/a
Earnings DateMar 27, 2026

About HKG:2877

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovas... [Read more]

Sector Healthcare
Founded 2002
Employees 2,822
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2877
Full Company Profile

Financial Performance

In 2025, HKG:2877's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements